heartdiseasefacts.com [ad_1]
Wu W, He J, Shao X. Trends in the incidence and mortality of congenital heart disease at the global, regional and country levels, 1990-2017. medicine. 2020;99:e20593.
Giang KW, Mandarenakis Z, Fedchenko M, Eriksson P, Rosengren A, Norman M et al. Congenital heart disease: changes in birth prevalence and cardiac intervention records over the past half century in Sweden. Eur J Prev Cardiol. 2023;30:169-76.
Egbe A, Lee S, Ho D, Uppu S, Srivastava S. Prevalence of congenital anomalies in newborns diagnosed with congenital heart disease. An Pediatr Cardiol. 2014;7:86.
Zimmerman MS. Global, regional, and national burden of congenital heart disease, 1990-2017: A systematic analysis of the Global Burden of Disease Study 2017. Lancet Child Adolesc Health. 2020;4:185-200.
Pierpont ME, Brueckner M, Chung WK, Garg V, Lacro RV, McGuire AL, et al. Genetic basis of congenital heart disease: revisited: American Heart Association scientific statement. Circulation. 2018;138:e653 – e711.
Morton SU, Kuat D, Seidman JG, Seidman CE. Genomic frontiers of congenital heart disease. Nat Pastor Cardiol. 2022;19:26 – 42.
Peyvandi S, Lupo PJ, Garbarini J, Woyciechowski S, Edman S, Emanuel BS, et al. 22q11.2 deletion in patients with conus stem defects: data from 1,610 consecutive cases. Pediatric Cardiol. 2013;34:1687-94.
Forstmann JAS, Jalali GR, Rappaport AM, Scott C, Emanuel BS, et al. MLPA: a rapid, reliable, and sensitive method for detecting and analyzing 22q aberrations. Ham Mutat. 2006;27:814-21.
Chais MA. Genetic testing in congenital heart disease: a clinical approach. World J Cardiol. 2016;8:180.
Smith HS, Swint JM, Lalani SR, Otto MCO, Yamal J, Russell HV, Comparison of exome sequencing and standard genetic testing for critically ill children with suspected other genetic disorders. Genet Medicine. 2020;22:1303–10.
Yang L, Wei Z, Chen X, Hu L, Peng X, Wang J, et al.
Meng L, Pammi M, Saronwala A, Magoulas P, Ghazi AR, Vetrini F, et al. Use of exome sequencing for infants in the intensive care unit. JAMA Pediatrics. 2017;171:e173438.
Wang H, Xiao F, Dong X, Yulan L, Cheng G, Wang L et al. Diagnostic and clinical utility of next-generation sequencing in children born with multiple congenital anomalies in the Chinese Neonatal Genome Project. Ham Mutat. 2021;42:434–44.
Wu B, Kang W, Wang Y, Zhuang D, Chen L, Pan X et al. In the Chinese Neonatal Genome Project, the application of full-spectrum rapid clinical genome sequencing improved the diagnostic yield and clinical outcomes of critically ill infants. Critical Care Med. 2021;49:1674–83.
Runke S, Eggers S, Wilson M, Patel C, Barnett C, Pinner J, et al. Feasibility of ultrafast exome sequencing in critically ill infants and children with suspected monogenic disease in the Australian public health system. jam. 2020;323:2503.
Dimock D, Kaylor S, Waldman B, Benson W, Ashburner C, Carmichael J, et al. Project Baby Bear: Rapid precision care incorporating rWGS improves clinical outcomes and reduces costs of care at five California children’s hospitals. reduction has been demonstrated. Am J Ham Junet. 2021;108:1231–8.
Bowling KM, Thompson ML, Finilla CR, Hyatt SM, Ratner DR, Amaral MD, et al. Genomic sequencing as a first-line diagnostic test for hospitalized infants. Genet Medicine. 2022;24:851–61.
Dagama AM, Del Rosario MC, Bresnahan MA, Yu TW, Wojcik MH, Agrawal PB. Integrating rapid exome sequencing into NICU clinical care after a pilot research study. NPJ Genome Medicine. 2022;7:51.
Findley TO, Crain AK, Mahajan S, Deniwar A, Davis J, Zavala AS, et al. Congenital heart disease and copy number mutations associated with neurodevelopmental disorders. Am J Med Genet A. 2022;188:13–23.
Elliott AM, Souich C, Lehman A, Guella I, Evans DM, Candido T, et al. Rapidomics: Rapid genome-wide sequencing in the neonatal intensive care unit – successes and challenges. Eur J Pediatr. 2019;178:1207–18.
Williamson SL, Rasanayagam CN, Grover KJ, Baptista J, Naik S, Satdia P, et al. Rapid exome sequencing: revolutionizing the management of acutely unwell neonates. Eur J Pediatr. 2021;180:3587–91.
Shikany AR, Landis BJ, Parrott A, Miller EM, Coyan A, Walters L. A comprehensive clinical genetics approach to severe congenital heart disease in infancy. J Pediatrics. 2020;227:231–238.e14.
Durbin MD, Helbati LR, Lee M, Ware SM. Multicenter cross-sectional studies of infants with congenital heart disease have demonstrated that genetic testing has a high diagnostic yield but that evaluation methods vary. June Med Open. 2023;1:100814.
Miller DT, Adam MP, Aradhya S, Biesecker LG, Brossman AR, Carter NP, et al. Consensus Statement: Chromosomal microarrays are first-line clinical diagnostic tests for individuals with developmental disorders or congenital abnormalities. Am J Ham Junet. 2010;86:749-64.
Gill K, Sasaki J, Jayakar P, Sosa L, Welch E. Chromosomal microarrays detect genetic risk for neurodevelopmental disorders in newborns with congenital heart disease. Cardiol Young. 2021;31:1275–82.
Wu X, Li R, Fu F, Pan M, Han J, Yang X et al. Chromosomal microarray analysis in a study of children with congenital heart disease. BMC Pediatrics. 2017;17:117.
Durbin MD, Fairman K, Helbati LR, Huang M, Lee M, Abreu D. Other genetic testing guidelines impact the care of newborns with congenital heart disease. J Pediatrics. 2023;260:113495.
Mone F, Eberhardt RY, Morris RK, Hurles ME, McMullan DJ, Maher ER, et al. CO congenital heart disease and the Diagnosis Efficiency with Exome Sequencing (CODE) study: Prospective cohort study and systematic review. Ultrasound obstetrics and gynecology. 2021;57:43-51.
Page SL, Saha P, Priest JR. Beyond gene panels: whole exome sequencing for the diagnosis of congenital heart disease. Circ Genom Precis Med. 2018;11:e002097.
[ad_2]
Source link
